Today, Bayer is a major international concern, the key to its success is a large-scale research activities focused on health care, plant protection, development and production of high-tech materials. This approach is reflected in the structure of the concern, which consists of three business units:
- Bayer CropScience AG - human nutrition and plant protection.
- Bayer MaterialScience AG - advanced high-tech material
- Bayer HealthCare AG - protecting human and animal health
- Each of the structures works as an independent company.
Although Bayer Company entered the market back in 1992, in fact, only now it began to present its pharmaceutical products not through the agency service, but independently.
All over the world Bayer Schering Pharma has a very ambitious goal - to become a leader in the field of specialized pharmaceuticals. To achieve this goal, six priority areas have been identified: diagnostic imaging, hematology/cardiology, oncology, general therapy, specialized therapy and women's health. Already this year, the expected annual turnover of 10 billion euros will allow Bayer Schering Pharma to take seventh place in the world among specialized pharmaceutical companies.
For many years, when prescribing Bayer products, they have not had direct contact with Bayer employees. Now communication will become more personal, and it will undoubtedly improve mutual understanding.
In the coming years, we have every chance to enter the largest OTC markets and take advantage of this growth - our direct task. To achieve this, we will expand the number of employees, provide advertising support for our drugs and look for new forms of work.